Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?

Table 6

Morbidity and mortality after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Año	Pats	PSM	Death	Morbi	Morbi dity	Common complications
	(𝑛)		(%)		Major	1st	2th	3th
Shen et al. [29], 2004	77		12	—	30	Haematological
Glehen et al. [27], 2003	216	Mixed	3.2	30.5	—	Intestinal perforation Anastomotic leak	Haematological	Íleus
Kusamura et al. [3], 2006	209	Mixed	0.9	—	30.5	Intestinal perforation/Anastomotic leak	Bleeding	Septicemia
Smeenk et al. [20], 2006	103	PMP	11	54	—	Infection	Intestinal perforation/Anastomotic leak	Cardiopulmonary
Gusani et al. [2], 2008	124	Mixed	1.6	56.5	54	Reoperation	Intestinal perforation/Anastomotic leak	Septicemia
Sugarbaker et al. [19], 2006	356	PMP	2.0	74.2	56.5	Hematological	Gastrointestinal	Cardiovascculary
Chen et al [26], 1997	42	Mixed		86	24	Atelectasis	Pleural effusion	Pulmonary edema pneumotorax pneumonia
Elias et al. [15], 1999	106	Mixed	4	—	41	Intestinal perforation/Anastomotic leak	pulmonar infection	—
Levine et al. [37], 2007	501	Mixed	4.3	43.1	—	—	—	—
Verwaal et al. [14], 2004	102	Mixed	7.8	65	43.1	Intestinal perforation/Anastomotic leak	Infection	Hematological
López-Basave et al. [31], 2011	24	Mixed	0	37		Diaphragmatic opening	Bleeding	Fístula,; pneumonia, Renal failure